Phacilitate Leaders World

Conference speakers

Akihiro Shimosaka

Dr Akihiro Shimosaka

Chairperson, Asian Cellular Therapy Organization (ACTO)

R & D experiences

From Discovery research to clinical development as well as regulatory frame work EPO, G-CSF, TPO, SCF, ?-galactosyl ceramide, DC, Exosome, Regenerative Cellular Therapy, Immuno Cellular Therapy, Regulatory activity to establish new standard for biologics and cellular products in USA, Europe and Asia

Business opportunity (in the past, but no business relationship with any company today)

Kirin, Kirin-Amgen, Miltenyi Biotec, Dendreon, Anosys, Cerus, Argos Involved in EPO production using CHO cell for the first time to establish standard for mammalian cell system. Worked with Dendreon for the first clinical study for DC therapy. Worked with Anosys for the first Exosome study for cancer treatment. Worked with Miltenyi biotec for regenerative therapy using CD133+/CD34+ cell. Worked for platelet production from iPS cell.


Director, Research and Development Division, Research Foundation for Community Medicine

Chairperson, Asian Cellular Therapy Organization, Secretary, International Society for Cellular Therapy Asian Region

Editorial Board Member for Cytotherapy, Associate Editor-in-Chief for J. Immuno Cell Therapy

Academic Position:

Hematology Institute, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking University, School of Oncology, Fourth Military Medical University, Heilongjiang Hematology Institute, Xi'an Jiaotong University, Dalian Nationality College


1969 B. Sc., Agricultural Department, University of Tokyo, Japan

1985 – 1986 Research Scientist, Institute of Applied Microbiology, University of Tokyo, Japan

1987 Ph. D., Agricultural Department, University of Tokyo, Japan

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman